Morgan Stanley Maintains Overweight on Eastman Chemical, Lowers Price Target to $79

Benzinga Newsdesk www.benzinga.com Negative 87.6%

Neg 87.6% Neu 0% Pos 0%

Morgan Stanley analyst Vincent Andrews maintains Eastman Chemical (NYSE:EMN) with a Overweight and lowers the price target from $83 to $79.